President Donald Trump on Saturday directed his administration to speed up reviews of certain psychedelic drugs, including ibogaine, which recently has been embraced by combat veterans and conservative lawmakers despite having serious safety risks.
Ibogaine is banned under the federal government's most restrictive category for illegal, high-risk drugs. But the administration is taking steps to ease access to psychedelics that Trump said were already designated as potential breakthroughs by federal regulators.
